Randomized Controlled Trial of the Medtronic Endeavor Drug-Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions - ENDEAVOR III: Follow-Up to 5 Years


The goal of the trial was to evaluate treatment with the Endeavor zotarolimus-eluting stent (ZES) compared with treatment with the Cypher sirolimus-eluting stent (SES) among patients with de novo coronary lesions.